Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Paris - Delayed Quote EUR

Crossject Société Anonyme (ALCJ.PA)

1.0000
+0.0010
+(0.10%)
At close: May 2 at 5:35:16 PM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ALCJ.PA

Recent News: ALCJ.PA

View More
CROSSJECT reports financial results for 2024

CROSSJECT reports financial results for 2024
GlobeNewswire last month
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program

CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
GlobeNewswire last month
CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones
GlobeNewswire last month
Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board
GlobeNewswire 2 months ago
COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE
GlobeNewswire 2 months ago
Crossject confirms ZEPIZURE® supply chain readiness with another successful ISO audit for Quality Management System

Crossject confirms ZEPIZURE® supply chain readiness with another successful ISO audit for Quality Management System
GlobeNewswire 4 months ago
Crossject announces the pricing of its reserved capital increase and warrants issuance for an aggregate amount of EUR 7.2M

Crossject announces the pricing of its reserved capital increase and warrants issuance for an aggregate amount of EUR 7.2M
GlobeNewswire 4 months ago
Crossject launches reserved capital increase and warrants issuance for an aggregate amount of at least €7m

Crossject launches reserved capital increase and warrants issuance for an aggregate amount of at least €7m
GlobeNewswire 4 months ago
Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement

Crossject and the U.S. Department of Defense Relaunch Joint Research on Needle-free Autoinjectors, Extending Their Cooperative Research and Development Agreement
GlobeNewswire 4 months ago
Crossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HAZMAT conditions

Crossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HAZMAT conditions
GlobeNewswire 5 months ago
Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization

Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization
GlobeNewswire 6 months ago
View More

Related Tickers

1SXP.DE SCHOTT Pharma AG & Co. KGaA
25.15
+1.62%
 
NYXH Nyxoah SA
6.10
+1.50%
 
DIM.PA Sartorius Stedim Biotech S.A.
211.50
+2.57%
 
ISRG Intuitive Surgical, Inc.
529.42
+2.37%